Rockwell Medical, Inc. (DE) Common Stock (RMTI) is a publicly traded Healthcare sector company. As of May 21, 2026, RMTI trades at $0.79 with a market cap of $30.84M and a P/E ratio of -5.45. RMTI moved +2.23% today. Year to date, RMTI is -17.00%; over the trailing twelve months it is -23.36%. Its 52-week range spans $0.74 to $5.15. Analyst consensus is buy with an average price target of $3.00. Rallies surfaces RMTI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
RMTI financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. RMTI recently traded at $0.79. Market cap is $30.84M. P/E ratio is -5.45. Revenue is $67.68M.
| Metric | Value |
|---|---|
| Price | $0.79 |
| Market Cap | $30.84M |
| P/E Ratio | -5.45 |
| EPS | $-0.15 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.15 |
| 52-Week Low | $0.74 |
| Volume | 9.71K |
| Avg Volume | 0 |
| Revenue (TTM) | $67.68M |
| Net Income | $-5.40M |
| Gross Margin | 17.07% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $69.26M | $-5.31M | $-0.15 |
| 2024 | $101.49M | $-480.00K | $-0.03 |
| 2023 | $83.61M | $-8.44M | $-0.37 |
| 2022 | $72.81M | $-18.68M | $-1.89 |
2 analysts cover RMTI: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $3.00.